
Musculoskeletal Drugs
Prescription drugs and medicines relating to the muscles and the bones of the body. Studies in this area include: aging, bone density, bone fractures, chronic back pain, hip replacement, osteoarthritis, osteoporosis, rheumatoid arthritis, spinal cord injuries, and others.
The list of FDA approved drugs for musculoskeletal appears below. Click any link to view the full drug information.
Number Of Musculoskeletal Drugs: 78
For the treatment of rheumatoid arthritis
For the treatment of systemic juvenile idiopathic arthritis
Combination hormone replacement therapy for the prevention of osteoporosis and other symptoms associated w/postmenopause
Treatment for Paget's Disease
For the treatment of Mucopolysaccharidosis I (MPS I) in subjects aged 5 to 65
Transdermal patch for the prevention of postmenopausal osteoporosis and treatment of vasomotor menopausal symptoms
For the improvement of walking in patients with multiple sclerosis
For the treatment of muscle spasm associated with acute, painful musculoskeletal conditions
Treatment for arthritis
Generic equivalent of Tracrium
For the treatment of multiple sclerosis
Extended release capsule for the relief of pain requiring continuous, around-the-clock therapy
For the treatment and prevention of osteoporosis
For the treatment of upper limb spasticity
For the treatment of rheumatoid arthritis
For gout flares and familial Mediterranean fever
For the relief of rheumatoid arthritis and osteoarthritis and prevention of gastric ulcers
For the treatment of Gaucher disease
Generic equivalent of Estrace
Treatment for the prevention of osteoporosis
Generic equivalent of Lodine
Generic equivalent of Lodine 500 mg tablets
Treatment for the prevention of osteoporosis
For the treatment/prevention of osteoporosis and reduction of breast cancer risk in postmenopausal women
Osteoporosis treatment
For the treatment of relapsing multiple sclerosis
Norethindrone acetate (1mg) and ethinyl estradiol tablets (5mcg)
For the treatment of Osteoporosis in postmenopausal women and men who are at high risk for a fracture.
Treatment for osteoporosis in women after menopause and Paget's Disease of Bone
For the treatment of growth failure in children who were born small for gestational age (SGA)
For the treatment of relapsing multiple sclerosis
Treatment for chronic moderate to severe pain
Generic equivalent or Oruvail
Injectable therapy for the treatment of rheumatoid arthritis
For the treatment of chronic gout (hyperuricemia)
Treatment for arthritis
Treatment for prevention of blood clots following hip-replacement surgery
For the treatment of neuropathic pain associated with spinal cord injury
Treatment for post-menopausal osteoporosis
For relief of the signs and symptoms of osteoarthritis
Injectable solution for the treatment of abnormal head position and neck pain associated with cervical dystonia
For the treatment of overactive bladder
For the treatment of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
Treatment for osteoarthritis and rheumatoid arthritis
For the treatment of Restless Legs Syndrome
For the treatment of Juvenile Idiopathic Arthritis
Treatment for pain associated with musculoskeletal conditions
For the treatment of osteoarthritis of the knee
For the prevention of postmenopausal osteoporosis and treatment of vasomotor menopause symptoms
Treatment for postmenopausal hormone replacement, postmenopausal osteoporosis
For the treatment of postmenopausal women with osteoporosis at high risk for fracture
For the treatment of certain inflammatory diseases, including arthritis, COPD, asthma and psoriatic conditions
For the treatment of postmenopausal osteoporosis
For the treatment of Paget's disease
Intravenous infusion for the treatment of rheumatoid arthritis
For the treatment of infantile spasms and complex partial seizures
Treatment for growth hormone deficiency and Turner Syndrome
For the treatment of fibromyalgia
Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery
For the treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Treatment for Paget?s disease of bone
For the treatment of acromegaly
Injectable formulation for the treatment of acromegaly
For the treatment of erectile dysfunction
Joint fluid therapy for treatment of osteoarthritis in the knee
For the treatment of pain associated with osteoarthritis of the knee
External cream for the treatment of male hormone deficiency.
Treatment for arthritis
Injectable agent for the treatment of multiple myeloma patients who have received at least two prior therapies.
For the treatment of arthritis in patients at risk for NSAID-associated ulcers
For the treatment of rheumatoid arthritis
For the prevention of post-menopausal osteoporosis
For the treatment of soft tissue sarcoma
For the treatment of chorea due to Huntington's disease
For the treatment of cervical dystonia and blepharospasm
For the prevention of skeletal-related events in patients with bone metastases from solid tumors
For the treatment of Dupuytren?s contracture
Treatment for muscle spasticity
FDA Approved Musculoskeletal Drugs Listings:
The rules of principle for evaluating MediLexicon's FDA musculoskeletal drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
The musculoskeletal drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.



